InvestorsHub Logo
icon url

Maciste

10/07/16 11:34 AM

#77135 RE: thesaud #77134

I honestly do not know. Anytime something like this happens it will have an effect on the SP whether is justified or not. Maybe Denner can speed up the selling process a little.

2da may have a better understanding of this. What do you think 2da?
icon url

Bxofscidad

10/07/16 2:39 PM

#77155 RE: thesaud #77134

This attempt to litigate is confusing.

It does not appear that they are attempting to certify a class action on behalf of the patients and Insurance companies, claiming that they paid too much for the drug. Based on the scant information in the news article, they are attempting to certify a class action on behalf of Ariad investors. As the price of the drug increased, rather then decreased, Ariad investors did not sustain stock losses, but stock gains, so where are the damages?

I hope someone can explain why this is being considered